

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine catabolic process (GO:0006554) | 7.22808609 |
| 2 | lysine metabolic process (GO:0006553) | 7.22808609 |
| 3 | tryptophan catabolic process (GO:0006569) | 6.24076929 |
| 4 | indole-containing compound catabolic process (GO:0042436) | 6.24076929 |
| 5 | indolalkylamine catabolic process (GO:0046218) | 6.24076929 |
| 6 | kynurenine metabolic process (GO:0070189) | 6.02471249 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.95230520 |
| 8 | cysteine metabolic process (GO:0006534) | 5.93130852 |
| 9 | drug transmembrane transport (GO:0006855) | 5.89772487 |
| 10 | tryptophan metabolic process (GO:0006568) | 5.78601823 |
| 11 | urate metabolic process (GO:0046415) | 5.74952438 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.62792114 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 5.62792114 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.53469448 |
| 15 | negative regulation of cell killing (GO:0031342) | 5.53469448 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 5.49844020 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.49844020 |
| 18 | 2-oxoglutarate metabolic process (GO:0006103) | 5.24354089 |
| 19 | drug transport (GO:0015893) | 5.22373023 |
| 20 | valine metabolic process (GO:0006573) | 5.17329259 |
| 21 | homocysteine metabolic process (GO:0050667) | 5.05878564 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.94077899 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.93142324 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 4.91117554 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 4.91117554 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.91117554 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.91117554 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.91117554 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 4.91117554 |
| 30 | organic cation transport (GO:0015695) | 4.90726264 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.87718957 |
| 32 | glyoxylate metabolic process (GO:0046487) | 4.83286135 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.69477797 |
| 34 | aspartate family amino acid catabolic process (GO:0009068) | 4.64426040 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.58699436 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.57444930 |
| 37 | response to peptidoglycan (GO:0032494) | 4.54419017 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 4.48862647 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 4.33349890 |
| 40 | detection of other organism (GO:0098543) | 4.32723422 |
| 41 | sulfur amino acid catabolic process (GO:0000098) | 4.29614285 |
| 42 | cellular modified amino acid catabolic process (GO:0042219) | 4.29352902 |
| 43 | indolalkylamine metabolic process (GO:0006586) | 4.23413465 |
| 44 | phosphate ion transport (GO:0006817) | 4.22105806 |
| 45 | quaternary ammonium group transport (GO:0015697) | 4.21351500 |
| 46 | glutamate metabolic process (GO:0006536) | 4.21215325 |
| 47 | aromatic amino acid family metabolic process (GO:0009072) | 4.14916052 |
| 48 | detection of bacterium (GO:0016045) | 4.11907093 |
| 49 | tricarboxylic acid metabolic process (GO:0072350) | 4.10882431 |
| 50 | short-chain fatty acid metabolic process (GO:0046459) | 4.07709324 |
| 51 | regulation of gamma-delta T cell activation (GO:0046643) | 4.05468080 |
| 52 | cellular biogenic amine catabolic process (GO:0042402) | 4.03418048 |
| 53 | amine catabolic process (GO:0009310) | 4.03418048 |
| 54 | carnitine transport (GO:0015879) | 4.02989404 |
| 55 | amino-acid betaine transport (GO:0015838) | 4.02989404 |
| 56 | leukocyte aggregation (GO:0070486) | 4.01113890 |
| 57 | carnitine metabolic process (GO:0009437) | 3.99338699 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 3.94838944 |
| 59 | branched-chain amino acid metabolic process (GO:0009081) | 3.94166662 |
| 60 | detection of molecule of bacterial origin (GO:0032490) | 3.93751219 |
| 61 | neutrophil activation involved in immune response (GO:0002283) | 3.93174131 |
| 62 | phosphate ion transmembrane transport (GO:0035435) | 3.92996175 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.87663521 |
| 64 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.86538105 |
| 65 | acetyl-CoA metabolic process (GO:0006084) | 3.86332149 |
| 66 | alpha-amino acid catabolic process (GO:1901606) | 3.84976700 |
| 67 | fatty acid beta-oxidation (GO:0006635) | 3.84314369 |
| 68 | regulation of cholesterol homeostasis (GO:2000188) | 3.84080497 |
| 69 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.83319825 |
| 70 | response to muramyl dipeptide (GO:0032495) | 3.83088888 |
| 71 | detection of external biotic stimulus (GO:0098581) | 3.80511541 |
| 72 | alpha-linolenic acid metabolic process (GO:0036109) | 3.79005126 |
| 73 | germinal center formation (GO:0002467) | 3.76860575 |
| 74 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.76655099 |
| 75 | response to mercury ion (GO:0046689) | 3.75276313 |
| 76 | fatty acid oxidation (GO:0019395) | 3.75137559 |
| 77 | lipid oxidation (GO:0034440) | 3.69695736 |
| 78 | urea cycle (GO:0000050) | 3.69360688 |
| 79 | urea metabolic process (GO:0019627) | 3.69360688 |
| 80 | cellular amino acid catabolic process (GO:0009063) | 3.69112290 |
| 81 | bile acid biosynthetic process (GO:0006699) | 3.68354232 |
| 82 | cellular extravasation (GO:0045123) | 3.67679140 |
| 83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.64558936 |
| 84 | serine family amino acid metabolic process (GO:0009069) | 3.63312724 |
| 85 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.63064009 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.60632682 |
| 87 | response to interleukin-15 (GO:0070672) | 3.58135759 |
| 88 | negative regulation of cholesterol transport (GO:0032375) | 3.58101860 |
| 89 | negative regulation of sterol transport (GO:0032372) | 3.58101860 |
| 90 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.57828473 |
| 91 | drug catabolic process (GO:0042737) | 3.57630507 |
| 92 | tolerance induction (GO:0002507) | 3.57441695 |
| 93 | fructose metabolic process (GO:0006000) | 3.56906337 |
| 94 | phospholipid homeostasis (GO:0055091) | 3.56114792 |
| 95 | cellular ketone body metabolic process (GO:0046950) | 3.55023912 |
| 96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.54298504 |
| 97 | toxin transport (GO:1901998) | 3.50548961 |
| 98 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.46695210 |
| 99 | response to host immune response (GO:0052572) | 3.46695210 |
| 100 | biotin metabolic process (GO:0006768) | 3.46045916 |
| 101 | response to type I interferon (GO:0034340) | 3.45533617 |
| 102 | type I interferon signaling pathway (GO:0060337) | 3.45095385 |
| 103 | cellular response to type I interferon (GO:0071357) | 3.45095385 |
| 104 | response to host defenses (GO:0052200) | 3.40020115 |
| 105 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.40020115 |
| 106 | response to host (GO:0075136) | 3.40020115 |
| 107 | nitrogen cycle metabolic process (GO:0071941) | 3.38465829 |
| 108 | detection of biotic stimulus (GO:0009595) | 3.34596893 |
| 109 | bile acid metabolic process (GO:0008206) | 3.32409955 |
| 110 | neutrophil activation (GO:0042119) | 3.30075666 |
| 111 | branched-chain amino acid catabolic process (GO:0009083) | 3.28691342 |
| 112 | organic acid catabolic process (GO:0016054) | 3.28660621 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.28660621 |
| 114 | oxaloacetate metabolic process (GO:0006107) | 3.28600265 |
| 115 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.28258623 |
| 116 | fatty acid catabolic process (GO:0009062) | 3.26383539 |
| 117 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.23011778 |
| 118 | NIK/NF-kappaB signaling (GO:0038061) | 3.21501087 |
| 119 | monocarboxylic acid catabolic process (GO:0072329) | 3.17761527 |
| 120 | negative regulation of T cell mediated immunity (GO:0002710) | 3.17253381 |
| 121 | carnitine transmembrane transport (GO:1902603) | 3.16604936 |
| 122 | negative thymic T cell selection (GO:0045060) | 3.16376202 |
| 123 | macrophage activation (GO:0042116) | 3.16010141 |
| 124 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.13726988 |
| 125 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.12714213 |
| 126 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.11977665 |
| 127 | protein carboxylation (GO:0018214) | 3.11977665 |
| 128 | granulocyte activation (GO:0036230) | 3.11499092 |
| 129 | excretion (GO:0007588) | 3.11125392 |
| 130 | response to phenylpropanoid (GO:0080184) | 3.08927975 |
| 131 | regulation of tolerance induction (GO:0002643) | 3.08922841 |
| 132 | indole-containing compound metabolic process (GO:0042430) | 3.08504951 |
| 133 | B cell receptor signaling pathway (GO:0050853) | 3.07816518 |
| 134 | cellular response to interleukin-15 (GO:0071350) | 3.06338780 |
| 135 | carnitine shuttle (GO:0006853) | 3.04939296 |
| 136 | immunoglobulin mediated immune response (GO:0016064) | 3.04529545 |
| 137 | tyrosine metabolic process (GO:0006570) | 3.01758327 |
| 138 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.01381867 |
| 139 | negative T cell selection (GO:0043383) | 3.00571149 |
| 140 | respiratory burst (GO:0045730) | 3.00541628 |
| 141 | fatty acid transmembrane transport (GO:1902001) | 2.99570110 |
| 142 | myeloid cell activation involved in immune response (GO:0002275) | 2.99343333 |
| 143 | ketone body metabolic process (GO:1902224) | 2.98367362 |
| 144 | dicarboxylic acid metabolic process (GO:0043648) | 2.97474563 |
| 145 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.97116241 |
| 146 | regulation of mast cell degranulation (GO:0043304) | 2.96932767 |
| 147 | serine family amino acid biosynthetic process (GO:0009070) | 2.96768819 |
| 148 | regulation of T cell tolerance induction (GO:0002664) | 2.96520247 |
| 149 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.96285259 |
| 150 | renal absorption (GO:0070293) | 2.95242950 |
| 151 | exogenous drug catabolic process (GO:0042738) | 2.95077001 |
| 152 | defense response to protozoan (GO:0042832) | 2.94061881 |
| 153 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93714793 |
| 154 | neutrophil mediated immunity (GO:0002446) | 2.93577514 |
| 155 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93534109 |
| 156 | proline metabolic process (GO:0006560) | 2.92480945 |
| 157 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.91985795 |
| 158 | microglial cell activation (GO:0001774) | 2.91875604 |
| 159 | macroautophagy (GO:0016236) | 2.91871610 |
| 160 | negative regulation of innate immune response (GO:0045824) | 2.91508601 |
| 161 | positive thymic T cell selection (GO:0045059) | 2.90545807 |
| 162 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90239446 |
| 163 | regulation of leukocyte degranulation (GO:0043300) | 2.87811188 |
| 164 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.87509266 |
| 165 | positive regulation of tolerance induction (GO:0002645) | 2.87420822 |
| 166 | regulation of triglyceride catabolic process (GO:0010896) | 2.86012312 |
| 167 | negative regulation of interleukin-6 production (GO:0032715) | 2.85711785 |
| 168 | coenzyme catabolic process (GO:0009109) | 2.83395312 |
| 169 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83223687 |
| 170 | complement activation, alternative pathway (GO:0006957) | 2.82690296 |
| 171 | regulation of necroptotic process (GO:0060544) | 2.82152885 |
| 172 | high-density lipoprotein particle remodeling (GO:0034375) | 2.81622295 |
| 173 | negative regulation of type 2 immune response (GO:0002829) | 2.80869395 |
| 174 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.80170782 |
| 175 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.79805184 |
| 176 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.79356058 |
| 177 | basic amino acid transport (GO:0015802) | 2.78550370 |
| 178 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.78474533 |
| 179 | thymic T cell selection (GO:0045061) | 2.77023367 |
| 180 | response to growth hormone (GO:0060416) | 2.75045795 |
| 181 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.74835364 |
| 182 | T cell selection (GO:0045058) | 2.73723741 |
| 183 | triglyceride homeostasis (GO:0070328) | 2.72600113 |
| 184 | acylglycerol homeostasis (GO:0055090) | 2.72600113 |
| 185 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.72084917 |
| 186 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.71383663 |
| 187 | T cell migration (GO:0072678) | 2.70930367 |
| 188 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.69918381 |
| 189 | positive regulation of interferon-alpha production (GO:0032727) | 2.69424001 |
| 190 | response to protozoan (GO:0001562) | 2.68520217 |
| 191 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.68317743 |
| 192 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.68317743 |
| 193 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.65844528 |
| 194 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.65020510 |
| 195 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.64693792 |
| 196 | myeloid dendritic cell differentiation (GO:0043011) | 2.64137088 |
| 197 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.63161796 |
| 198 | positive regulation of type 2 immune response (GO:0002830) | 2.61846026 |
| 199 | dendritic cell chemotaxis (GO:0002407) | 2.59178192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.96896296 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.48728758 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.97114059 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.44255697 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.47422110 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.29209926 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.20019047 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.14422457 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.07806907 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03947536 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.64593413 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.51905082 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.33924714 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.24304279 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17528883 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12587025 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.01270402 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00676606 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.90601963 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84983702 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.83224942 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81760515 |
| 23 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.70738158 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62492757 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62349122 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61314559 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60298272 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59215476 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51454997 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.48729225 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47917733 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46197293 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46027607 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45588502 |
| 35 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.43890244 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42275829 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41952362 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.40584537 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40526623 |
| 40 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40320773 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40150045 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40082628 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38511239 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37505296 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.37469063 |
| 46 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37144350 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34988481 |
| 48 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.34175252 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33853264 |
| 50 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.32372902 |
| 51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32149728 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.31082239 |
| 53 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.30260877 |
| 54 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30189366 |
| 55 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28836999 |
| 56 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.27898885 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25838400 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.25182665 |
| 59 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24433627 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23812251 |
| 61 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23226581 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22415588 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21502700 |
| 64 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21368311 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19179282 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18179890 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17858702 |
| 68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.16769692 |
| 69 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.13094428 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12990037 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12777231 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11335724 |
| 73 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10451923 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10418167 |
| 75 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10405964 |
| 76 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10405964 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10368593 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10323330 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10174249 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08511758 |
| 81 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08229659 |
| 82 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06921658 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06373510 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06359988 |
| 85 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05915720 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04881839 |
| 87 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.03457327 |
| 88 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02044211 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01701462 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01237764 |
| 91 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01097166 |
| 92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00848190 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98570265 |
| 94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.97680889 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97549077 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97028634 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.96891532 |
| 98 | * MYB_26560356_Chip-Seq_TH2_Human | 0.96237865 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95740331 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94415900 |
| 101 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94064049 |
| 102 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.93564766 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93168630 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93134934 |
| 105 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93015348 |
| 106 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91683377 |
| 107 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91197234 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88629277 |
| 109 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87359059 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87344349 |
| 111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86618419 |
| 112 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.86178647 |
| 113 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.85720313 |
| 114 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.84409679 |
| 115 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84380775 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84113629 |
| 117 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.83554559 |
| 118 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82720322 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82639177 |
| 120 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82527038 |
| 121 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81755683 |
| 122 | P68_20966046_ChIP-Seq_HELA_Human | 0.81504526 |
| 123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81471264 |
| 124 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80210434 |
| 125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80043433 |
| 126 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.79994687 |
| 127 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79796556 |
| 128 | MAF_26560356_Chip-Seq_TH2_Human | 0.79207937 |
| 129 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76934902 |
| 130 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76543522 |
| 131 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.76533802 |
| 132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76245711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.04221870 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.75626848 |
| 3 | MP0005365_abnormal_bile_salt | 4.39419922 |
| 4 | MP0003303_peritoneal_inflammation | 3.89889315 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.72410596 |
| 6 | MP0003195_calcinosis | 3.37275549 |
| 7 | MP0005332_abnormal_amino_acid | 3.35036898 |
| 8 | MP0003252_abnormal_bile_duct | 3.32835946 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.26966547 |
| 10 | MP0004043_abnormal_pH_regulation | 3.02941605 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.89470293 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.72917452 |
| 13 | MP0009785_altered_susceptibility_to | 2.59158473 |
| 14 | MP0009643_abnormal_urine_homeostasis | 2.51829384 |
| 15 | MP0005671_abnormal_response_to | 2.42013482 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.40539783 |
| 17 | MP0008961_abnormal_basal_metabolism | 2.32740056 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.26875485 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.22103235 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.21542676 |
| 21 | MP0001819_abnormal_immune_cell | 2.19763812 |
| 22 | MP0008260_abnormal_autophagy | 2.14907756 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.12947199 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.07717637 |
| 25 | MP0001666_abnormal_nutrient_absorption | 2.04697990 |
| 26 | MP0002405_respiratory_system_inflammati | 2.01156036 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.90544871 |
| 28 | MP0005670_abnormal_white_adipose | 1.87339807 |
| 29 | MP0001756_abnormal_urination | 1.85159050 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.83102270 |
| 31 | MP0000609_abnormal_liver_physiology | 1.80198827 |
| 32 | MP0009840_abnormal_foam_cell | 1.76134766 |
| 33 | MP0001765_abnormal_ion_homeostasis | 1.74212942 |
| 34 | MP0004510_myositis | 1.72718136 |
| 35 | MP0002398_abnormal_bone_marrow | 1.70813089 |
| 36 | MP0002136_abnormal_kidney_physiology | 1.68733342 |
| 37 | MP0000716_abnormal_immune_system | 1.68481884 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.60850284 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.59672346 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.59418073 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 1.55890315 |
| 42 | MP0005083_abnormal_biliary_tract | 1.54163690 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.52850158 |
| 44 | MP0003878_abnormal_ear_physiology | 1.52609359 |
| 45 | MP0005377_hearing/vestibular/ear_phenot | 1.52609359 |
| 46 | MP0002928_abnormal_bile_duct | 1.50893608 |
| 47 | MP0000858_altered_metastatic_potential | 1.50234937 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.49036110 |
| 49 | MP0003828_pulmonary_edema | 1.48820442 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46259748 |
| 51 | MP0002132_abnormal_respiratory_system | 1.45267256 |
| 52 | MP0000569_abnormal_digit_pigmentation | 1.45143658 |
| 53 | MP0003868_abnormal_feces_composition | 1.43291499 |
| 54 | MP0002722_abnormal_immune_system | 1.43004975 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.40911562 |
| 56 | MP0001764_abnormal_homeostasis | 1.38965482 |
| 57 | MP0002429_abnormal_blood_cell | 1.32956741 |
| 58 | MP0004381_abnormal_hair_follicle | 1.32889345 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.31979296 |
| 60 | MP0005310_abnormal_salivary_gland | 1.31950806 |
| 61 | MP0003075_altered_response_to | 1.28478296 |
| 62 | MP0004264_abnormal_extraembryonic_tissu | 1.26748944 |
| 63 | MP0001851_eye_inflammation | 1.26521151 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.23950498 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.22418370 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.22418370 |
| 67 | MP0004130_abnormal_muscle_cell | 1.14102763 |
| 68 | MP0003436_decreased_susceptibility_to | 1.13933958 |
| 69 | MP0004883_abnormal_blood_vessel | 1.09828259 |
| 70 | MP0001790_abnormal_immune_system | 1.08046580 |
| 71 | MP0005387_immune_system_phenotype | 1.08046580 |
| 72 | MP0001853_heart_inflammation | 1.08040203 |
| 73 | MP0009764_decreased_sensitivity_to | 1.07577678 |
| 74 | MP0008469_abnormal_protein_level | 1.05737474 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.05194115 |
| 76 | MP0003091_abnormal_cell_migration | 1.04769586 |
| 77 | MP0005166_decreased_susceptibility_to | 1.04095672 |
| 78 | MP0003690_abnormal_glial_cell | 1.03069919 |
| 79 | MP0005164_abnormal_response_to | 1.03034995 |
| 80 | MP0008004_abnormal_stomach_pH | 1.02333248 |
| 81 | MP0000598_abnormal_liver_morphology | 1.01892590 |
| 82 | MP0005220_abnormal_exocrine_pancreas | 0.97098408 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 0.96678364 |
| 84 | MP0002933_joint_inflammation | 0.96343331 |
| 85 | MP0002168_other_aberrant_phenotype | 0.96027922 |
| 86 | MP0003448_altered_tumor_morphology | 0.95019628 |
| 87 | MP0000685_abnormal_immune_system | 0.94636464 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.94373250 |
| 89 | MP0003283_abnormal_digestive_organ | 0.94349752 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.93627318 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.93006995 |
| 92 | MP0001835_abnormal_antigen_presentation | 0.92748604 |
| 93 | MP0009642_abnormal_blood_homeostasis | 0.92417811 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.91269454 |
| 95 | MP0003646_muscle_fatigue | 0.90382100 |
| 96 | MP0003724_increased_susceptibility_to | 0.89307698 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.88928767 |
| 98 | MP0005535_abnormal_body_temperature | 0.87527147 |
| 99 | MP0004808_abnormal_hematopoietic_stem | 0.87507727 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.87289925 |
| 101 | MP0005390_skeleton_phenotype | 0.87231173 |
| 102 | MP0000371_diluted_coat_color | 0.87199495 |
| 103 | MP0001800_abnormal_humoral_immune | 0.85703890 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.84055479 |
| 105 | MP0001663_abnormal_digestive_system | 0.83584760 |
| 106 | MP0002396_abnormal_hematopoietic_system | 0.82922497 |
| 107 | MP0002876_abnormal_thyroid_physiology | 0.80735778 |
| 108 | MP0003045_fibrosis | 0.79005527 |
| 109 | MP0000538_abnormal_urinary_bladder | 0.79001996 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.78279408 |
| 111 | MP0002135_abnormal_kidney_morphology | 0.76155672 |
| 112 | MP0000249_abnormal_blood_vessel | 0.76134169 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.75088839 |
| 114 | MP0003763_abnormal_thymus_physiology | 0.75025389 |
| 115 | MP0009763_increased_sensitivity_to | 0.75005234 |
| 116 | MP0006082_CNS_inflammation | 0.74715193 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.73804326 |
| 118 | MP0009278_abnormal_bone_marrow | 0.73804241 |
| 119 | MP0010155_abnormal_intestine_physiology | 0.73164358 |
| 120 | MP0003705_abnormal_hypodermis_morpholog | 0.73103648 |
| 121 | MP0000343_altered_response_to | 0.72800715 |
| 122 | MP0003795_abnormal_bone_structure | 0.72082326 |
| 123 | MP0001661_extended_life_span | 0.71344211 |
| 124 | MP0002009_preneoplasia | 0.70575747 |
| 125 | MP0002254_reproductive_system_inflammat | 0.69679966 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.69558916 |
| 127 | MP0003186_abnormal_redox_activity | 0.69460568 |
| 128 | MP0005334_abnormal_fat_pad | 0.68787248 |
| 129 | MP0003329_amyloid_beta_deposits | 0.68252582 |
| 130 | MP0008874_decreased_physiological_sensi | 0.66953627 |
| 131 | MP0002723_abnormal_immune_serum | 0.65883695 |
| 132 | MP0000689_abnormal_spleen_morphology | 0.65805614 |
| 133 | MP0003866_abnormal_defecation | 0.65197461 |
| 134 | MP0004947_skin_inflammation | 0.64149162 |
| 135 | MP0002971_abnormal_brown_adipose | 0.63975833 |
| 136 | MP0005025_abnormal_response_to | 0.63926651 |
| 137 | MP0000490_abnormal_crypts_of | 0.63373355 |
| 138 | MP0001849_ear_inflammation | 0.63302774 |
| 139 | MP0002419_abnormal_innate_immunity | 0.62711584 |
| 140 | MP0002269_muscular_atrophy | 0.62670915 |
| 141 | MP0005375_adipose_tissue_phenotype | 0.62196953 |
| 142 | MP0005647_abnormal_sex_gland | 0.62150265 |
| 143 | MP0002006_tumorigenesis | 0.62099856 |
| 144 | MP0001873_stomach_inflammation | 0.62053999 |
| 145 | MP0000604_amyloidosis | 0.61564430 |
| 146 | MP0005023_abnormal_wound_healing | 0.61092288 |
| 147 | MP0005000_abnormal_immune_tolerance | 0.60838643 |
| 148 | MP0002877_abnormal_melanocyte_morpholog | 0.60056830 |
| 149 | MP0001944_abnormal_pancreas_morphology | 0.59887742 |
| 150 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59462652 |
| 151 | MP0009780_abnormal_chondrocyte_physiolo | 0.58621219 |
| 152 | MP0002452_abnormal_antigen_presenting | 0.57424756 |
| 153 | MP0000230_abnormal_systemic_arterial | 0.57049968 |
| 154 | MP0005451_abnormal_body_composition | 0.56718830 |
| 155 | MP0001958_emphysema | 0.56507376 |
| 156 | MP0003953_abnormal_hormone_level | 0.56155541 |
| 157 | MP0003959_abnormal_lean_body | 0.54386418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.03848928 |
| 2 | Gout (HP:0001997) | 5.41297710 |
| 3 | Hyperglycinuria (HP:0003108) | 5.03664939 |
| 4 | Myositis (HP:0100614) | 4.88945114 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.73070611 |
| 6 | Orchitis (HP:0100796) | 4.70827973 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.69503632 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.58586614 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.57321518 |
| 10 | Increased circulating renin level (HP:0000848) | 4.46033986 |
| 11 | Ketoacidosis (HP:0001993) | 4.43235535 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.40741966 |
| 13 | Optic neuritis (HP:0100653) | 4.40741966 |
| 14 | Hyperactive renin-angiotensin system (HP:0000841) | 4.36876974 |
| 15 | Ketosis (HP:0001946) | 4.29867408 |
| 16 | Metabolic alkalosis (HP:0200114) | 4.27626429 |
| 17 | Increased purine levels (HP:0004368) | 4.24896937 |
| 18 | Hyperuricemia (HP:0002149) | 4.24896937 |
| 19 | Abnormality of purine metabolism (HP:0004352) | 4.23094043 |
| 20 | Hypomagnesemia (HP:0002917) | 4.19850093 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.16608155 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.09709630 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 4.09709630 |
| 24 | Abnormal urine output (HP:0012590) | 4.09041958 |
| 25 | Polyuria (HP:0000103) | 4.07207323 |
| 26 | Hypokalemic alkalosis (HP:0001949) | 4.06151079 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.93669331 |
| 28 | Stomatitis (HP:0010280) | 3.82218907 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.81434432 |
| 30 | Abnormality of chloride homeostasis (HP:0011422) | 3.77355277 |
| 31 | Proximal tubulopathy (HP:0000114) | 3.65305646 |
| 32 | Abnormality of renal excretion (HP:0011036) | 3.59311671 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58911497 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 3.57516447 |
| 35 | Recurrent fungal infections (HP:0002841) | 3.54738483 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.53121283 |
| 37 | Abnormal drinking behavior (HP:0030082) | 3.49392030 |
| 38 | Polydipsia (HP:0001959) | 3.49392030 |
| 39 | Tetany (HP:0001281) | 3.46819639 |
| 40 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.46724543 |
| 41 | Abnormality of magnesium homeostasis (HP:0004921) | 3.44757435 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 3.44540182 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.38095853 |
| 44 | Intrahepatic cholestasis (HP:0001406) | 3.33967405 |
| 45 | Alkalosis (HP:0001948) | 3.32071436 |
| 46 | Gingivitis (HP:0000230) | 3.23824993 |
| 47 | Increased IgE level (HP:0003212) | 3.22346680 |
| 48 | Hyperammonemia (HP:0001987) | 3.20070555 |
| 49 | Meningitis (HP:0001287) | 3.19846312 |
| 50 | Hyperglycinemia (HP:0002154) | 3.19785563 |
| 51 | Xanthomatosis (HP:0000991) | 3.18613700 |
| 52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.16481793 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 3.15659514 |
| 54 | Obstructive lung disease (HP:0006536) | 3.15659514 |
| 55 | Keratoconjunctivitis sicca (HP:0001097) | 3.14442019 |
| 56 | Recurrent skin infections (HP:0001581) | 3.14316504 |
| 57 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.12976904 |
| 58 | Hypoglycemic coma (HP:0001325) | 3.12702477 |
| 59 | Vasculitis (HP:0002633) | 3.06211000 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.96445300 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.88619592 |
| 62 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.88619592 |
| 63 | Abnormality of renin-angiotensin system (HP:0000847) | 2.86855288 |
| 64 | Joint hemorrhage (HP:0005261) | 2.83202174 |
| 65 | Cellulitis (HP:0100658) | 2.81810842 |
| 66 | Keratoconjunctivitis (HP:0001096) | 2.81223089 |
| 67 | Deep venous thrombosis (HP:0002625) | 2.80571447 |
| 68 | Encephalitis (HP:0002383) | 2.80457646 |
| 69 | Generalized aminoaciduria (HP:0002909) | 2.75402585 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.70663061 |
| 71 | T lymphocytopenia (HP:0005403) | 2.70608624 |
| 72 | Hyperaldosteronism (HP:0000859) | 2.69722938 |
| 73 | Recurrent viral infections (HP:0004429) | 2.66272942 |
| 74 | Urticaria (HP:0001025) | 2.64465240 |
| 75 | Abnormality of the fingertips (HP:0001211) | 2.64307506 |
| 76 | Renal salt wasting (HP:0000127) | 2.63263630 |
| 77 | Metabolic acidosis (HP:0001942) | 2.58569366 |
| 78 | Pustule (HP:0200039) | 2.58188094 |
| 79 | Arterial thrombosis (HP:0004420) | 2.57797787 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.57147210 |
| 81 | Renal tubular acidosis (HP:0001947) | 2.55354419 |
| 82 | Delayed CNS myelination (HP:0002188) | 2.52013544 |
| 83 | Chest pain (HP:0100749) | 2.51731610 |
| 84 | Abnormality of T cell number (HP:0011839) | 2.51707296 |
| 85 | Hypercalciuria (HP:0002150) | 2.51328067 |
| 86 | Myocardial infarction (HP:0001658) | 2.50850183 |
| 87 | Gingival bleeding (HP:0000225) | 2.50405197 |
| 88 | Hemoptysis (HP:0002105) | 2.49651930 |
| 89 | Increased IgM level (HP:0003496) | 2.49304207 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 2.48540691 |
| 91 | Inflammation of the large intestine (HP:0002037) | 2.46122775 |
| 92 | Nasal polyposis (HP:0100582) | 2.41598228 |
| 93 | Amyloidosis (HP:0011034) | 2.40195084 |
| 94 | Abnormality of proline metabolism (HP:0010907) | 2.39547442 |
| 95 | Hydroxyprolinuria (HP:0003080) | 2.39547442 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 2.37054564 |
| 97 | Autoimmune thrombocytopenia (HP:0001973) | 2.36669444 |
| 98 | Epistaxis (HP:0000421) | 2.33512172 |
| 99 | Nephrocalcinosis (HP:0000121) | 2.32438504 |
| 100 | Loss of speech (HP:0002371) | 2.30350404 |
| 101 | Peritonitis (HP:0002586) | 2.28885230 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28748586 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 2.28748586 |
| 104 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.28557925 |
| 105 | Prolonged partial thromboplastin time (HP:0003645) | 2.28244020 |
| 106 | Abnormality of glycolipid metabolism (HP:0010969) | 2.27873961 |
| 107 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.27873961 |
| 108 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.27873961 |
| 109 | Nephrolithiasis (HP:0000787) | 2.27064348 |
| 110 | Enlarged kidneys (HP:0000105) | 2.26907994 |
| 111 | Hyperlipoproteinemia (HP:0010980) | 2.26556107 |
| 112 | Abnormality of the common coagulation pathway (HP:0010990) | 2.25405762 |
| 113 | Pulmonary embolism (HP:0002204) | 2.25248217 |
| 114 | Hypokalemia (HP:0002900) | 2.24529024 |
| 115 | Leukocytosis (HP:0001974) | 2.23209254 |
| 116 | Vascular calcification (HP:0004934) | 2.22636520 |
| 117 | Complement deficiency (HP:0004431) | 2.22527175 |
| 118 | Interstitial pulmonary disease (HP:0006530) | 2.20270409 |
| 119 | Slow saccadic eye movements (HP:0000514) | 2.19466968 |
| 120 | Granulocytopenia (HP:0001913) | 2.19040740 |
| 121 | Hypochromic anemia (HP:0001931) | 2.18772459 |
| 122 | Recurrent bronchitis (HP:0002837) | 2.17972750 |
| 123 | Obstructive sleep apnea (HP:0002870) | 2.17837205 |
| 124 | Anorexia (HP:0002039) | 2.17513823 |
| 125 | Abnormality of the nasal mucosa (HP:0000433) | 2.17279563 |
| 126 | Episodic fever (HP:0001954) | 2.13366868 |
| 127 | Abnormality of T cells (HP:0002843) | 2.13195362 |
| 128 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.13175763 |
| 129 | Hemorrhage of the eye (HP:0011885) | 2.12630033 |
| 130 | Osteomyelitis (HP:0002754) | 2.10702247 |
| 131 | Hypergammaglobulinemia (HP:0010702) | 2.09958284 |
| 132 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.09940788 |
| 133 | Gastrointestinal stroma tumor (HP:0100723) | 2.09736671 |
| 134 | Gangrene (HP:0100758) | 2.09588519 |
| 135 | Increased serum ferritin (HP:0003281) | 2.09073629 |
| 136 | Hypoglycemic seizures (HP:0002173) | 2.08489744 |
| 137 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07272596 |
| 138 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07272596 |
| 139 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07272596 |
| 140 | Abnormality of potassium homeostasis (HP:0011042) | 2.05196744 |
| 141 | Hypochromic microcytic anemia (HP:0004840) | 2.05103844 |
| 142 | Late onset (HP:0003584) | 2.04455830 |
| 143 | Purpura (HP:0000979) | 2.02909969 |
| 144 | Fat malabsorption (HP:0002630) | 2.02575399 |
| 145 | Hypophosphatemia (HP:0002148) | 2.02020663 |
| 146 | Hypoalphalipoproteinemia (HP:0003233) | 2.01762385 |
| 147 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00567878 |
| 148 | Mucopolysacchariduria (HP:0008155) | 2.00567878 |
| 149 | Mitral stenosis (HP:0001718) | 1.99691465 |
| 150 | Vomiting (HP:0002013) | 1.99543278 |
| 151 | Panhypogammaglobulinemia (HP:0003139) | 1.99190780 |
| 152 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98611847 |
| 153 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97569221 |
| 154 | Abnormality of the intrinsic pathway (HP:0010989) | 1.96820063 |
| 155 | Abnormality of the endocardium (HP:0004306) | 1.96148326 |
| 156 | Fatigue (HP:0012378) | 1.94877395 |
| 157 | Epidermoid cyst (HP:0200040) | 1.94463889 |
| 158 | Recurrent sinusitis (HP:0011108) | 1.93610666 |
| 159 | Acne (HP:0001061) | 1.92860269 |
| 160 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.91656145 |
| 161 | Systemic lupus erythematosus (HP:0002725) | 1.91545054 |
| 162 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90991135 |
| 163 | Abnormality of the peritoneum (HP:0002585) | 1.89522273 |
| 164 | Restrictive lung disease (HP:0002091) | 1.89427221 |
| 165 | Lymphopenia (HP:0001888) | 1.89315202 |
| 166 | Vacuolated lymphocytes (HP:0001922) | 1.89302349 |
| 167 | Confusion (HP:0001289) | 1.88809507 |
| 168 | Abnormality of methionine metabolism (HP:0010901) | 1.88107693 |
| 169 | Abnormality of the pleura (HP:0002103) | 1.87662031 |
| 170 | Cardiovascular calcification (HP:0011915) | 1.86985370 |
| 171 | Joint swelling (HP:0001386) | 1.85982119 |
| 172 | Hepatocellular carcinoma (HP:0001402) | 1.85317706 |
| 173 | Hyperbilirubinemia (HP:0002904) | 1.84885473 |
| 174 | Sepsis (HP:0100806) | 1.84289688 |
| 175 | Premature loss of primary teeth (HP:0006323) | 1.84202098 |
| 176 | Abnormality of serum amino acid levels (HP:0003112) | 1.83457254 |
| 177 | Autoimmune hemolytic anemia (HP:0001890) | 1.82204775 |
| 178 | Glomerulopathy (HP:0100820) | 1.82098128 |
| 179 | Sensorimotor neuropathy (HP:0007141) | 1.81817368 |
| 180 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.80435967 |
| 181 | Facial shape deformation (HP:0011334) | 1.80191655 |
| 182 | Potter facies (HP:0002009) | 1.80191655 |
| 183 | Chronic otitis media (HP:0000389) | 1.80019631 |
| 184 | Glycosuria (HP:0003076) | 1.79652137 |
| 185 | Abnormality of urine glucose concentration (HP:0011016) | 1.79652137 |
| 186 | Malnutrition (HP:0004395) | 1.79449679 |
| 187 | Abnormality of T cell physiology (HP:0011840) | 1.79322512 |
| 188 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78652414 |
| 189 | Dysostosis multiplex (HP:0000943) | 1.78091302 |
| 190 | Colitis (HP:0002583) | 1.77829289 |
| 191 | Esophageal varix (HP:0002040) | 1.77371889 |
| 192 | Neonatal onset (HP:0003623) | 1.77332773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 4.75190601 |
| 2 | ERN1 | 4.01217094 |
| 3 | RIPK4 | 3.51910371 |
| 4 | MAP4K1 | 3.08865030 |
| 5 | PRPF4B | 2.92982824 |
| 6 | BCKDK | 2.80572670 |
| 7 | WNK4 | 2.49330361 |
| 8 | FGFR4 | 2.37922874 |
| 9 | SIK1 | 2.26242125 |
| 10 | OXSR1 | 2.18276161 |
| 11 | INSRR | 2.09793118 |
| 12 | TAOK3 | 2.04340282 |
| 13 | MAP3K14 | 1.93119454 |
| 14 | TRIB3 | 1.87906159 |
| 15 | CDK12 | 1.78890227 |
| 16 | IRAK3 | 1.72595210 |
| 17 | TYK2 | 1.71736608 |
| 18 | TNK2 | 1.68702223 |
| 19 | JAK1 | 1.65289179 |
| 20 | MAP3K13 | 1.64282068 |
| 21 | SIK3 | 1.63783603 |
| 22 | SGK3 | 1.62281142 |
| 23 | MAP3K10 | 1.60907635 |
| 24 | MAP3K7 | 1.57997650 |
| 25 | FES | 1.48926537 |
| 26 | TXK | 1.47542361 |
| 27 | ZAP70 | 1.45122582 |
| 28 | SGK2 | 1.41131621 |
| 29 | MAP3K1 | 1.39425722 |
| 30 | CAMK1D | 1.35046567 |
| 31 | FGR | 1.33862470 |
| 32 | PKN2 | 1.32335029 |
| 33 | SMG1 | 1.30750293 |
| 34 | CAMK1G | 1.28686744 |
| 35 | KSR2 | 1.28122119 |
| 36 | PTK6 | 1.27917670 |
| 37 | RIPK1 | 1.26589172 |
| 38 | JAK3 | 1.23981672 |
| 39 | ICK | 1.20879157 |
| 40 | JAK2 | 1.12360343 |
| 41 | MAP2K3 | 1.09225490 |
| 42 | BRD4 | 1.07498933 |
| 43 | SGK494 | 1.06861483 |
| 44 | SGK223 | 1.06861483 |
| 45 | IRAK1 | 1.05722816 |
| 46 | IKBKE | 1.05616428 |
| 47 | MATK | 1.04975134 |
| 48 | SIK2 | 1.04546362 |
| 49 | WNK1 | 1.03116486 |
| 50 | IRAK2 | 1.03014237 |
| 51 | TTN | 1.01906308 |
| 52 | TBK1 | 1.01428608 |
| 53 | TGFBR2 | 1.00983737 |
| 54 | NEK1 | 1.00642482 |
| 55 | PRKAA1 | 0.97996917 |
| 56 | PRKCH | 0.96501735 |
| 57 | EPHB1 | 0.94862397 |
| 58 | EPHA3 | 0.93201719 |
| 59 | GRK6 | 0.93189593 |
| 60 | CSK | 0.93156231 |
| 61 | TAOK1 | 0.92871178 |
| 62 | PDK4 | 0.92661766 |
| 63 | PDK3 | 0.92661766 |
| 64 | LYN | 0.92637438 |
| 65 | MTOR | 0.92348071 |
| 66 | MAPK11 | 0.87548199 |
| 67 | ITK | 0.87487986 |
| 68 | PRKAA2 | 0.87372951 |
| 69 | NEK9 | 0.85088394 |
| 70 | MAP3K2 | 0.84763240 |
| 71 | MAP3K6 | 0.83956855 |
| 72 | STK38 | 0.82799520 |
| 73 | FLT3 | 0.82207128 |
| 74 | KIT | 0.78272705 |
| 75 | FGFR3 | 0.77719920 |
| 76 | CHUK | 0.77329168 |
| 77 | YES1 | 0.76570599 |
| 78 | TESK2 | 0.75760143 |
| 79 | PIK3CG | 0.74855304 |
| 80 | BTK | 0.73836286 |
| 81 | EEF2K | 0.72508321 |
| 82 | CAMKK1 | 0.67988175 |
| 83 | CSF1R | 0.67576785 |
| 84 | BLK | 0.67266400 |
| 85 | HCK | 0.62382668 |
| 86 | BMPR2 | 0.60816224 |
| 87 | PINK1 | 0.59855750 |
| 88 | MAPK15 | 0.58291883 |
| 89 | TEC | 0.57843633 |
| 90 | DYRK1B | 0.57732729 |
| 91 | SYK | 0.56861160 |
| 92 | STK10 | 0.56664218 |
| 93 | LATS1 | 0.56177217 |
| 94 | RET | 0.55789122 |
| 95 | GSK3A | 0.55776572 |
| 96 | SGK1 | 0.54675683 |
| 97 | PTK2 | 0.54477298 |
| 98 | PDK1 | 0.54293866 |
| 99 | MAP3K3 | 0.52437916 |
| 100 | LCK | 0.51708718 |
| 101 | CDK6 | 0.51392172 |
| 102 | IRAK4 | 0.50900520 |
| 103 | IKBKB | 0.49122589 |
| 104 | CAMK4 | 0.48868336 |
| 105 | HIPK2 | 0.48843171 |
| 106 | MARK3 | 0.48216323 |
| 107 | CDC42BPA | 0.48038097 |
| 108 | MAPK7 | 0.47705752 |
| 109 | FYN | 0.46033878 |
| 110 | NLK | 0.45703439 |
| 111 | LRRK2 | 0.45698627 |
| 112 | MAPK12 | 0.45649693 |
| 113 | PRKD2 | 0.45413351 |
| 114 | MAP3K11 | 0.45148593 |
| 115 | RPS6KC1 | 0.45087287 |
| 116 | RPS6KL1 | 0.45087287 |
| 117 | PIM1 | 0.44116038 |
| 118 | MAP2K6 | 0.44032787 |
| 119 | MARK2 | 0.42031672 |
| 120 | PDK2 | 0.40957218 |
| 121 | MAP2K2 | 0.38916787 |
| 122 | PTK2B | 0.38891204 |
| 123 | PDGFRB | 0.38805927 |
| 124 | PDGFRA | 0.38162892 |
| 125 | CDK4 | 0.37573407 |
| 126 | MAPKAPK2 | 0.37193497 |
| 127 | PDPK1 | 0.37162599 |
| 128 | NEK2 | 0.35156708 |
| 129 | MAP3K5 | 0.34589969 |
| 130 | MELK | 0.33703659 |
| 131 | RPS6KA2 | 0.33222014 |
| 132 | RPS6KA6 | 0.33200909 |
| 133 | TAOK2 | 0.33090359 |
| 134 | BMX | 0.32792103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.86632169 |
| 2 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.85637447 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.84779245 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.82759263 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.76693585 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.75566545 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73769625 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.70973530 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.53898118 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.47858443 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.47739765 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.47710975 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46618030 |
| 14 | Lysine degradation_Homo sapiens_hsa00310 | 2.24870032 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.24004380 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.16526230 |
| 17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.05735384 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03425626 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99491797 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.91751193 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90618480 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.87439205 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.83319387 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.82926438 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.80568655 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.79479747 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78394176 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77732108 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.70595254 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67456350 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67433423 |
| 32 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.66609499 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.65630679 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.62958264 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.62660046 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.62475048 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.60692028 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.60159556 |
| 39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.53758790 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53346522 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48346690 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45240901 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.44477598 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42912479 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42612959 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.42304884 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37615940 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.34148205 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33678795 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.33611509 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.33323016 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29203745 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28401515 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27106467 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26833155 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 1.22954576 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22372899 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22085031 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22062322 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20967838 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18783086 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18258908 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.17800007 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 1.15853901 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14458318 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09467538 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08612173 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07371988 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06382119 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05969197 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05070854 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04786255 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04434428 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02024397 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01917059 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01865539 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01317603 |
| 78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00685585 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 1.00081224 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97749066 |
| 81 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93743088 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91608400 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.91418796 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.91258558 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.91256169 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90478197 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89604945 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.89388863 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.88154745 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88102481 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.88001851 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87480171 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84448892 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.83152836 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80516807 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80007338 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79733889 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78882599 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77487142 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77342514 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76952492 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76557791 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76340707 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76204311 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74507933 |
| 106 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74232660 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74022168 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.72754292 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72273753 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71105004 |
| 111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68180490 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67925306 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67552084 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.66877251 |
| 115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66396061 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66083875 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65415123 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65230842 |
| 119 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.64861955 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64671161 |
| 121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64401935 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.64359534 |
| 123 | Asthma_Homo sapiens_hsa05310 | 0.63503943 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62792079 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62182458 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61843117 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59854964 |
| 128 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59492930 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58674751 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.56321383 |
| 131 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56139651 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55438556 |
| 133 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55334207 |
| 134 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54385352 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52547755 |
| 136 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52345928 |
| 137 | Glioma_Homo sapiens_hsa05214 | 0.52319028 |
| 138 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52003830 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50943051 |
| 140 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50668647 |
| 141 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50122483 |
| 142 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50090886 |
| 143 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48749623 |
| 144 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48178319 |
| 145 | Prion diseases_Homo sapiens_hsa05020 | 0.47890085 |
| 146 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47450227 |
| 147 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45225978 |
| 148 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44897796 |
| 149 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43242391 |
| 150 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43176352 |
| 151 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42437701 |
| 152 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40571560 |
| 153 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36943898 |
| 154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36595779 |
| 155 | Hepatitis C_Homo sapiens_hsa05160 | 0.35723403 |
| 156 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35464733 |
| 157 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34894617 |
| 158 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34097638 |
| 159 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29804415 |
| 160 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28030198 |
| 161 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26279482 |
| 162 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.23949114 |
| 163 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23608268 |
| 164 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.23449546 |
| 165 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22919155 |
| 166 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.21409352 |
| 167 | Mineral absorption_Homo sapiens_hsa04978 | 0.20221054 |
| 168 | Measles_Homo sapiens_hsa05162 | 0.19980066 |
| 169 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.19461180 |
| 170 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18985805 |
| 171 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.18560373 |
| 172 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17863005 |
| 173 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14983743 |
| 174 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.14574349 |
| 175 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.14152260 |

